|
|
Volumn 131, Issue 11, 2008, Pages 438-439
|
|
Treatment of Behcet's disease with adalimumab;Adalimumab en el tratamiento de la enfermedad de Behçet
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
COLCHICINE;
CYCLOSPORIN A;
METHOTREXATE;
PREDNISONE;
PROTEIN P55;
PROTEIN P75;
TUMOR NECROSIS FACTOR ANTIBODY;
ANTIINFLAMMATORY AGENT;
DERMATOLOGICAL AGENT;
MONOCLONAL ANTIBODY;
ADULT;
ANGIONEUROTIC EDEMA;
APOPTOSIS;
BEHCET DISEASE;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
LETTER;
MALE;
REMISSION;
TREATMENT OUTCOME;
URTICARIA;
VASCULITIS;
MIDDLE AGED;
NOTE;
SUBCUTANEOUS DRUG ADMINISTRATION;
TIME;
ADULT;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
BEHCET SYNDROME;
DERMATOLOGIC AGENTS;
FEMALE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
MALE;
METHOTREXATE;
MIDDLE AGED;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 58149218918
PISSN: 00257753
EISSN: 15788989
Source Type: Journal
DOI: 10.1157/13126223 Document Type: Letter |
|
Times cited : (8)
|
|
References (4)
|
